Federated Hermes’s Cross Country Healthcare CCRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-302
| Closed | -$4.5K | – | 2078 |
|
|
2025
Q1 | $4.5K | Sell |
302
-190
| -39% | -$3.26K | ﹤0.01% | 1886 |
|
|
2024
Q4 | $8.94K | Sell |
492
-56
| -10% | -$754 | ﹤0.01% | 1849 |
|
|
2024
Q3 | $7.37K | Sell |
548
-12,448
| -96% | -$184K | ﹤0.01% | 1826 |
|
|
2024
Q2 | $180K | Sell |
12,996
-6,779
| -34% | -$107K | ﹤0.01% | 1496 |
|
|
2024
Q1 | $370K | Sell |
19,775
-315,707
| -94% | -$6.31M | ﹤0.01% | 1385 |
|
|
2023
Q4 | $7.6M | Sell |
335,482
-201,991
| -38% | -$4.38M | 0.02% | 624 |
|
|
2023
Q3 | $13.3M | Sell |
537,473
-29,508
| -5% | -$743K | 0.04% | 467 |
|
|
2023
Q2 | $15.9M | Buy |
566,981
+223,914
| +65% | +$5.56M | 0.04% | 445 |
|
|
2023
Q1 | $7.66M | Buy |
343,067
+161,223
| +89% | +$4.22M | 0.02% | 608 |
|
|
2022
Q4 | $4.83M | Buy |
181,844
+169,506
| +1,374% | +$5.53M | 0.01% | 689 |
|
|
2022
Q3 | $350K | Buy |
12,338
+12,022
| +3,804% | +$309K | ﹤0.01% | 1421 |
|
|
2022
Q2 | $7K | Sell |
316
-373,582
| -100% | -$7M | ﹤0.01% | 1856 |
|
|
2022
Q1 | $8.1M | Sell |
373,898
-56,636
| -13% | -$1.23M | 0.02% | 659 |
|
|
2021
Q4 | $12M | Sell |
430,534
-400
| -0.1% | -$9.7K | 0.02% | 598 |
|
|
2021
Q3 | $9.15M | Buy |
430,934
+15,348
| +4% | +$288K | 0.02% | 670 |
|
|
2021
Q2 | $6.86M | Buy |
415,586
+133,008
| +47% | +$2.03M | 0.01% | 753 |
|
|
2021
Q1 | $3.53M | Buy |
282,578
+418
| +0.1% | +$4.43K | 0.01% | 943 |
|
|
2020
Q4 | $2.5M | Buy |
282,160
+381
| +0.1% | +$3.1K | 0.01% | 986 |
|
|
2020
Q3 | $1.83M | Buy |
281,779
+63,558
| +29% | +$403K | ﹤0.01% | 1030 |
|
|
2020
Q2 | $1.34M | Buy |
218,221
+217,067
| +18,810% | +$1.33M | ﹤0.01% | 1133 |
|
|
2020
Q1 | $8K | Buy |
1,154
+19
| +2% | +$180 | ﹤0.01% | 1882 |
|
|
2019
Q4 | $13K | Buy |
1,135
+753
| +197% | +$8.5K | ﹤0.01% | 1882 |
|
|
2019
Q3 | $4K | Buy |
+382
| New | +$3.76K | ﹤0.01% | 1968 |
|
|
2018
Q1 | – | Sell |
-1,608
| Closed | -$21K | – | 2161 |
|
|
2017
Q4 | $21K | Sell |
1,608
-116,566
| -99% | -$1.54M | ﹤0.01% | 1760 |
|
|
2017
Q3 | $1.68M | Sell |
118,174
-81
| -0.1% | -$1.01K | ﹤0.01% | 996 |
|
|
2017
Q2 | $1.53M | Sell |
118,255
-42,443
| -26% | -$547K | ﹤0.01% | 1053 |
|
|
2017
Q1 | $2.31M | Buy |
160,698
+43,370
| +37% | +$638K | 0.01% | 852 |
|
|
2016
Q4 | $1.83M | Buy |
117,328
+20,580
| +21% | +$282K | 0.01% | 905 |
|
|
2016
Q3 | $1.14M | Sell |
96,748
-7,804
| -7% | -$103K | ﹤0.01% | 1063 |
|
|
2016
Q2 | $1.46M | Sell |
104,552
-5,782
| -5% | -$76.6K | ﹤0.01% | 969 |
|
|
2016
Q1 | $1.28M | Buy |
110,334
+34,225
| +45% | +$435K | ﹤0.01% | 1014 |
|
|
2015
Q4 | $1.25M | Buy |
76,109
+76,048
| +124,669% | +$1.21M | ﹤0.01% | 1046 |
|
|
2015
Q3 | $1K | Buy |
+61
| New | +$829 | ﹤0.01% | 1893 |
|
|
2015
Q1 | – | Sell |
-794
| Closed | -$10K | – | 2010 |
|
|
2014
Q4 | $10K | Buy |
+794
| New | +$8.11K | ﹤0.01% | 1742 |
|
|
2014
Q3 | – | Sell |
-13
| Closed | -$1K | – | 1991 |
|
|
2014
Q2 | $1K | Buy |
+13
| New | +$86 | ﹤0.01% | 1933 |
|
Other funds holding CCRN
MF
OBAM
AAM
Federated Hermes's CCRN Position: Q2 2025 in Review
Federated Hermes sold out of Cross Country Healthcare (CCRN) in Q2 2025, closing a stake of 302 shares — an estimated $4.5K sold.
Federated Hermes first reported a position in CCRN in Q2 2014 and held it in 35 quarters. The position peaked at $15.9M in Q2 2023. 161 funds tracked by Wall St. Rank hold CCRN as of Q2 2025.
- Federated Hermes reported no remaining Cross Country Healthcare position as of Q2 2025 after selling out during the quarter.
- Federated Hermes sold 302 Cross Country Healthcare shares in Q2 2025, an estimated $4.5K.
- Federated Hermes first reported a position in Cross Country Healthcare in Q2 2014 and held it in 35 quarters.
- Federated Hermes's Cross Country Healthcare position peaked at $15.9M in Q2 2023.
- 161 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2025.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.